Molbio Diagnostics has announced that it has acquired a 70 per cent stake in Bengaluru-based Prognosys Medical Systems, a manufacturer of the Prorad range of digital X-ray units and C-arms and developer of a comprehensive digital health platform.
The recent introduction of the unique PRORAD portable and ultra-portable digital x-ray units manufactured, for the first time in India, by Prognosys can deliver high-quality chest images combined with artificial intelligence (AI)-driven algorithms for automated interpreting and reporting at the point of care. The combination of PRORAD and Truenat systems offers a game-changing solution for screening and confirming large populations for highly contagious and devastating diseases such as TB, COVID, and other chest anomalies, the company said in a statement to the press.
Emphasising Molbio’s commitment to bringing a range of cost-effective, high-quality point-of-care solutions, Sriram Natarajan, CEO, Founder, and Director, Molbio Diagnostics, said: “The majority acquisition of Prognosys Medical Systems Private Limited is yet another step in this direction and helps us expand our “universal access” portfolio. Such solutions are going to alter the way we identify and treat communicable and non-communicable diseases that are currently difficult to eradicate. We are proud that the entire solution is being designed, developed, and manufactured in India for the world.”
Molbio Diagnostics will offer this technology along with its patented Truenat technology, a point-of-care, portable, battery-operated real-time PCR platform that can screen over 40 diseases with a sample-to-result time of 60 minutes.
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
Krishna Prasad, President, Prognosys, also commented and said, “We are truly excited about this partnership with Molbio Diagnostics, a pioneer in the industry that develops path breaking technologies in molecular diagnostics and the IVD field. We are certain that with our combined capabilities to design and build world-class solutions in India, a true “Make in India” initiative, we will be able to significantly enhance the efforts of the government to eradicate deadly diseases like tuberculosis.”
As per Molbio Diagnostics, both companies are already working together on mobile solutions for end-to-end screening and diagnosis of MTB and E-Clinics for delivering comprehensive health care, aiming to reach the last mile.
Source: Health.EconomicTimes.Indiatimes
